The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL
 Washington, D.C. 20549
FORM 13F
OMB Number:   3235-0006
Estimated average burden
hours per response:       23.8


FORM 13F COVER PAGE


Report for the Calendar Year or Quarter Ended:
06-30-2026
 
Check here if Amendment:      Amendment Number:
 
This Amendment (Check only one.):    is a restatement.
     adds new holdings entries.

Institutional Investment Manager Filing this Report:

Name:Alphabet Inc. 
Address:1600 Amphitheatre Parkway 
 Mountain View CA 94043 

Form 13F File Number:  028-22702 
CRD Number (if applicable):   
SEC File Number (if applicable):  028-22702 


The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:

Name:Marsida Saraci 
Title:VP, Corporate Controller and Principal Accounting Officer 
Phone: 650-253-0000 

Signature, Place, and Date of Signing:

/s/ Marsida Saraci Mountain View,  CALIFORNIA 08-06-2026 
[Signature][City, State][Date]

Do you wish to provide information pursuant to Special Instruction 5?        Yes      X  No

Report Type (Check only one.):

X  13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)

     13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)

     13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)


Form 13F Summary Page

Report Summary:

Number of Other Included Managers:
Form 13F Information table Entry Total:29 
Form 13F Information table Value Total:99,082,057,675 
 (round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F number(s) of all institutional investement managers with respect to which this report is filed, other than the manager filing this report.

   No.NameForm 13F File NumberCRD No. (if applicable)SEC File No. (if applicable)CIK
GV Management Company, L.L.C. 028-22704   0001940173 
Google LLC 028-22705   0001824723 
CapitalG II LP 028-22706   0001779076 

FORM 13F INFORMATION TABLE

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
NAME OF ISSUER TITLE OF CLASS CUSIPFIGI VALUE
(round to nearest dollar)
SHRS OR
PRN AMT
SH /
PRN
PUT /
CALL
INVESTMENT
DISCRETION
OTHER
MANAGER
VOTING AUTHORITY
SOLESHAREDNONE
ARM HOLDINGS PLCSPONSORED ADS042068205-695,235,1831,960,784SH-DFND201,960,7840
AST SPACEMOBILE INCCOM CL A00217D100-794,718,1668,943,486SH-DFND2010,904,2700
AUTOLUS THERAPEUTICS PLCSPON ADS05280R100-1,117,219698,262SH-DFND10698,2620
BEAM THERAPEUTICS INCCOM07373V105-11,037,449321,604SH-DFND10321,6040
BRIDGEBIO ONCOLOGY THERAPEUTCOM NEW107924102-21,512,2202,823,126SH-DFND102,823,1260
CME GROUP INCCOM12572Q105-769,376,1373,484,020SH-DFND203,484,0200
ETHOS TECHNOLOGIES INCCL A29765A101-65,714,0373,622,604SH-DFND103,622,6040
FERVO ENERGY COCL A COM31556C106-51,466,2021,760,732SH-DFND201,760,7320
FIGMA INCCLASS A COM STK316841105-3,899,878215,582SH-DFND10215,5820
FRESHWORKS INCCLASS A COM358054104-144,992,00314,327,273SH-DFND-014,327,2730
FRESHWORKS INCCLASS A COM358054104-19,019,2241,879,370SH-DFND301,879,3700
GITLAB INCCLASS A COM37637K108-83,185,4572,724,712SH-DFND102,724,7120
HYPERFINE INCCOM CL A44916K106-1,213,272898,720SH-DFND10898,7200
LYELL IMMUNOPHARMA INCCOM NEW55083R203-4,120,247293,256SH-DFND10293,2560
MAZE THERAPEUTICS INCCOM578784100-41,435,3171,388,583SH-DFND101,388,5830
MONTE ROSA THERAPEUTICS INCCOM61225M102-9,013,871372,474SH-DFND10372,4740
OSCAR HEALTH INCCL A687793109-13,746,298481,988SH-DFND10481,9880
PARABILIS MEDICINES INCCOM698955101-134,646,6604,919,498SH-DFND104,919,4980
PAYPAY CORPSPONSORED ADS70450C101-44,781,2503,125,000SH-DFND203,125,0000
PLANET LABS PBCCOM CL A72703X106-1,167,795,84935,248,893SH-DFND2035,248,8930
PRIME MEDICINE INCCOM74168J101-61,115,61816,562,498SH-DFND1016,562,4980
RELAY THERAPEUTICS INCCOM75943R102-26,381,6431,410,029SH-DFND101,410,0290
REVOLUTION MEDICINES INCCOM76155X100-551,842,8062,946,619SH-DFND102,946,6190
SANA BIOTECHNOLOGY INCCOM799566104-9,815,6252,812,500SH-DFND102,812,5000
SPACE EXPLORATION TECHN CORPCLASS A COM STK84615Q103-94,176,237,970551,189,500SH-DFND20551,189,5000
SPERO THERAPEUTICS INCCOM84833T103-1,966,854889,979SH-DFND10889,9790
TEMPUS AI INCCL A88023B103-89,855,3391,551,102SH-DFND201,551,1020
UIPATH INCCL A90364P105-76,463,2437,034,337SH-DFND307,034,3370
VERA THERAPEUTICS INCCL A92337R101-10,352,638241,264SH-DFND10241,2640